Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy
Cardiotoxicity associated with chemotherapy, also known as Cancer Therapy-Related Cardiac Dysfunction (CTRCD), affects 10% of patients undergoing chemotherapy and is the most undesirable side effect of chemotherapy. Over time, it is anticipated that there would be an increase in the number of cancer...
Main Authors: | Muhammad Yamin, Simon Salim, Muhammad Syahrir Azizi, Lusiani Rusdi, Aru Wisaksono Sudoyo, Anneira Amanda Putri |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2023-10-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://actamedindones.org/index.php/ijim/article/view/2440 |
Similar Items
-
Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)
by: Daniela Di Lisi, et al.
Published: (2023-11-01) -
Higher Incidence of Cancer Therapy-Related Cardiac Dysfunction in the COVID-19 Era: A Single Cardio-Oncology Center Experience
by: Daniela Di Lisi, et al.
Published: (2023-01-01) -
Right ventricle involvement in patients with breast cancer treated with chemotherapy
by: Ludovico Rossetto, et al.
Published: (2024-04-01) -
Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
by: Irene Cartas‐Espinel, et al.
Published: (2022-06-01) -
Role of advanced cardiovascular imaging in chemotherapy-induced cardiotoxicity
by: Maria Teresa Cannizzaro, et al.
Published: (2023-04-01)